Taste receptor signaling in beta cells and role in postprandial insulin secretion
β细胞中的味觉受体信号传导及其在餐后胰岛素分泌中的作用
基本信息
- 批准号:8004544
- 负责人:
- 金额:$ 5.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-12-01 至 2012-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAmino AcidsBeta CellBiosensorCalciumCellsCellular StressChronicComplications of Diabetes MellitusFailureGlucoseIn VitroInsulinIslets of LangerhansKnock-outKnockout MiceMediatingMetabolicMetabolic PathwayMonosaccharidesNon-Insulin-Dependent Diabetes MellitusNutrientPancreasPathway interactionsPhenotypePhysiologicalReceptor SignalingRegulationRegulatory PathwayRoleSignal PathwaySignal TransductionStructure of beta Cell of isletSystemTaste PerceptionTongueblood glucose regulationin vivoinsulin secretionisletnovelpreventpublic health relevancereceptorresearch studyresponsesensory systemsweet taste perceptiontherapeutic target
项目摘要
DESCRIPTION (provided by applicant): We recently discovered that pancreatic beta-cells express a signaling system complementary to the traditional glucose-induced metabolic pathway that participates in the stimulation of insulin release. Taste receptors (TRs) and their signaling machinery that are traditionally involved in taste perception on the tongue are also expressed in pancreatic islets. We found that TR agonists stimulate insulin secretion in primary pancreatic islets, and that these responses can be blocked using antagonists and knock out strategies targeting TR signaling components. This proposal addresses the physiological relevance of these findings. We hypothesize that the TR machinery in 2-cells is an important sensory system that modulates insulin secretion in response to ingested nutrients, such as monosaccharides and amino acids. We propose that TR signaling in 2-cells contributes to postprandial glucose homeostasis by modulating the effects of glucose-stimulated insulin secretion (GSIS). Our experimental plan evaluates the role of TRs in 2-cells, and elucidates the downstream signaling pathway induced by physiological TR agonists. We will use T1R3 knock out (KO) mice to investigate the role of TRs in the regulation of insulin secretion in vitro and glucose homeostasis in vivo. We will compare in vitro GSIS between wild type and T1R3 KO islets in static and perifusion experiments, and assess the in vivo metabolic phenotype of T1R3 KO mice subjected to 2-cell stress. We will also identify postprandial sweet taste nutrients that act through TRs to potentiate insulin release. Finally, we will elucidate the TR signaling pathway by evaluating the activation of PLC using a PLC-biosensor (PHPLC4-GFP), and analyze dynamic changes in ER calcium using a specific ER calcium biosensor (D1ER cameleon). Results from these studies will greatly enhance our understanding of the regulation of insulin release and confirm a novel regulatory pathway mediated by TRs present in 2-cells.
描述(由申请人提供):我们最近发现胰腺β细胞表达与传统葡萄糖诱导的代谢途径互补的信号传导系统,其参与胰岛素释放的刺激。传统上参与舌头味觉感知的味觉受体(TR)及其信号传导机制也在胰岛中表达。我们发现TR激动剂刺激原代胰岛中的胰岛素分泌,并且这些反应可以使用拮抗剂和敲除靶向TR信号传导组分的策略来阻断。本提案涉及这些发现的生理相关性。我们假设2-细胞中的TR机制是一个重要的感觉系统,它调节胰岛素分泌以响应摄入的营养物质,如单糖和氨基酸。我们认为2-细胞中的TR信号通过调节葡萄糖刺激的胰岛素分泌(GSIS)的作用而有助于餐后葡萄糖稳态。我们的实验计划评估TR在2-细胞中的作用,并阐明生理性TR激动剂诱导的下游信号通路。我们将使用T1 R3基因敲除(KO)小鼠来研究TRs在体外胰岛素分泌和体内葡萄糖稳态调节中的作用。我们将在静态和灌流实验中比较野生型和T1 R3 KO胰岛之间的体外GSIS,并评估T1 R3 KO小鼠在2细胞应激下的体内代谢表型。我们还将确定餐后甜味营养素,通过TRs的行为,以加强胰岛素的释放。最后,我们将通过使用PLC生物传感器(PHPLC 4-GFP)评估PLC的激活来阐明TR信号通路,并使用特定的ER钙生物传感器(D1 ER cameleon)分析ER钙的动态变化。这些研究的结果将极大地增强我们对胰岛素释放调节的理解,并证实2-细胞中存在的TRs介导的一种新的调节途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George Kyriazis其他文献
George Kyriazis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George Kyriazis', 18)}}的其他基金
Receptor-mediated glucose sensing and skeletal muscle function
受体介导的葡萄糖传感和骨骼肌功能
- 批准号:
10318085 - 财政年份:2021
- 资助金额:
$ 5.05万 - 项目类别:
Receptor-mediated glucose sensing and skeletal muscle function
受体介导的葡萄糖传感和骨骼肌功能
- 批准号:
10540309 - 财政年份:2021
- 资助金额:
$ 5.05万 - 项目类别:
Receptor-mediated glucose sensing and skeletal muscle function
受体介导的葡萄糖传感和骨骼肌功能
- 批准号:
10095313 - 财政年份:2021
- 资助金额:
$ 5.05万 - 项目类别:
Contribution of sweet taste receptors (STRs) to saccharin-induced alterations of gut microbiota
甜味受体(STR)对糖精诱导的肠道微生物群改变的贡献
- 批准号:
9376608 - 财政年份:2017
- 资助金额:
$ 5.05万 - 项目类别:
Taste receptor signaling in beta cells and role in postprandial insulin secretion
β细胞中的味觉受体信号传导及其在餐后胰岛素分泌中的作用
- 批准号:
8152145 - 财政年份:2010
- 资助金额:
$ 5.05万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 5.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 5.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 5.05万 - 项目类别: